FERMENTALG (ALGAE.PA) Fundamental Analysis & Valuation

EPA:ALGAE • FR0011271600

Current stock price

0.517 EUR
-0.02 (-3.72%)
Last:

This ALGAE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALGAE.PA Profitability Analysis

1.1 Basic Checks

  • ALGAE had negative earnings in the past year.
  • In the past year ALGAE has reported a negative cash flow from operations.
  • In the past 5 years ALGAE always reported negative net income.
  • In the past 5 years ALGAE always reported negative operating cash flow.
ALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFALGAE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -24.56%, ALGAE is doing worse than 91.30% of the companies in the same industry.
  • ALGAE has a Return On Equity of -38.02%. This is amonst the worse of the industry: ALGAE underperforms 86.96% of its industry peers.
Industry RankSector Rank
ROA -24.56%
ROE -38.02%
ROIC N/A
ROA(3y)-23.5%
ROA(5y)-19.63%
ROE(3y)-36.23%
ROE(5y)-31.43%
ROIC(3y)N/A
ROIC(5y)N/A
ALGAE.PA Yearly ROA, ROE, ROICALGAE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 20.94%, ALGAE is doing worse than 69.57% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALGAE has declined.
  • The Profit Margin and Operating Margin are not available for ALGAE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.82%
GM growth 5YN/A
ALGAE.PA Yearly Profit, Operating, Gross MarginsALGAE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALGAE.PA Health Analysis

2.1 Basic Checks

  • ALGAE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALGAE has more shares outstanding than it did 1 year ago.
  • ALGAE has more shares outstanding than it did 5 years ago.
  • ALGAE has a better debt/assets ratio than last year.
ALGAE.PA Yearly Shares OutstandingALGAE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALGAE.PA Yearly Total Debt VS Total AssetsALGAE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 1.59, we must say that ALGAE is in the distress zone and has some risk of bankruptcy.
  • ALGAE's Altman-Z score of 1.59 is on the low side compared to the rest of the industry. ALGAE is outperformed by 73.91% of its industry peers.
  • A Debt/Equity ratio of 0.12 indicates that ALGAE is not too dependend on debt financing.
  • ALGAE's Debt to Equity ratio of 0.12 is fine compared to the rest of the industry. ALGAE outperforms 79.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACCN/A
WACC6.2%
ALGAE.PA Yearly LT Debt VS Equity VS FCFALGAE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 1.88 indicates that ALGAE should not have too much problems paying its short term obligations.
  • ALGAE has a Current ratio of 1.88. This is comparable to the rest of the industry: ALGAE outperforms 55.07% of its industry peers.
  • ALGAE has a Quick Ratio of 1.83. This is a normal value and indicates that ALGAE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.83, ALGAE belongs to the top of the industry, outperforming 81.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.83
ALGAE.PA Yearly Current Assets VS Current LiabilitesALGAE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ALGAE.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 55.44% over the past year.
  • The Revenue has grown by 59.05% in the past year. This is a very strong growth!
  • ALGAE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.52% yearly.
EPS 1Y (TTM)55.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.36%
Revenue 1Y (TTM)59.05%
Revenue growth 3Y26.74%
Revenue growth 5Y43.52%
Sales Q2Q%20.35%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.96% on average over the next years. This is quite good.
  • Based on estimates for the next years, ALGAE will show a very strong growth in Revenue. The Revenue will grow by 39.99% on average per year.
EPS Next Y38.46%
EPS Next 2Y24.03%
EPS Next 3Y24.36%
EPS Next 5Y17.96%
Revenue Next Year16.52%
Revenue Next 2Y31.88%
Revenue Next 3Y44.92%
Revenue Next 5Y39.99%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALGAE.PA Yearly Revenue VS EstimatesALGAE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
ALGAE.PA Yearly EPS VS EstimatesALGAE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALGAE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALGAE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALGAE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGAE.PA Price Earnings VS Forward Price EarningsALGAE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALGAE.PA Per share dataALGAE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALGAE's earnings are expected to grow with 24.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.03%
EPS Next 3Y24.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALGAE.PA Dividend Analysis

5.1 Amount

  • No dividends for ALGAE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALGAE.PA Fundamentals: All Metrics, Ratios and Statistics

FERMENTALG

EPA:ALGAE (4/2/2026, 7:00:00 PM)

0.517

-0.02 (-3.72%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-02
Earnings (Next)05-05
Inst Owners25.95%
Inst Owner ChangeN/A
Ins Owners2.02%
Ins Owner ChangeN/A
Market Cap46.45M
Revenue(TTM)12.78M
Net Income(TTM)-11.54M
Analysts84.44
Price Target0.66 (27.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.63
P/FCF N/A
P/OCF N/A
P/B 1.53
P/tB 2.97
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.14
BVpS0.34
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.56%
ROE -38.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.94%
FCFM N/A
ROA(3y)-23.5%
ROA(5y)-19.63%
ROE(3y)-36.23%
ROE(5y)-31.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.82%
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.25%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.83
Altman-Z 1.59
F-Score6
WACC6.2%
ROIC/WACCN/A
Cap/Depr(3y)32.24%
Cap/Depr(5y)108.18%
Cap/Sales(3y)12.02%
Cap/Sales(5y)34.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.36%
EPS Next Y38.46%
EPS Next 2Y24.03%
EPS Next 3Y24.36%
EPS Next 5Y17.96%
Revenue 1Y (TTM)59.05%
Revenue growth 3Y26.74%
Revenue growth 5Y43.52%
Sales Q2Q%20.35%
Revenue Next Year16.52%
Revenue Next 2Y31.88%
Revenue Next 3Y44.92%
Revenue Next 5Y39.99%
EBIT growth 1Y15.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.04%
EBIT Next 3Y29.01%
EBIT Next 5Y22.54%
FCF growth 1Y49.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.34%
OCF growth 3YN/A
OCF growth 5YN/A

FERMENTALG / ALGAE.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FERMENTALG (ALGAE.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALGAE.PA.


Can you provide the valuation status for FERMENTALG?

ChartMill assigns a valuation rating of 1 / 10 to FERMENTALG (ALGAE.PA). This can be considered as Overvalued.


What is the profitability of ALGAE stock?

FERMENTALG (ALGAE.PA) has a profitability rating of 0 / 10.


What is the financial health of FERMENTALG (ALGAE.PA) stock?

The financial health rating of FERMENTALG (ALGAE.PA) is 3 / 10.